Medication info

Essentamin Injection 5%

Prescription medicationInjectionsExpired
Ingredient · strength
L-Isoleucine›650mg / 100mLL-Leucine›818mg / 100mLL-Lysine Acetate›606mg / 100mLL-Methionine›40mg / 100mLL-Phenylalanine›55mg / 100mLL-Threonine›275mg / 100mLL-Tryptophan›44mg / 100mLL-Valine›630mg / 100mLL-Arginine›670mg / 100mLL-Histidine›175mg / 100mLL-Alanine›290mg / 100mLGlycine›373mg / 100mLL-Proline›358mg / 100mLL-Serine›140mg / 100mLN-Acetyl-L-Cysteine›70mg / 100mL
Manufacturer / importer
Kujoo Pharmaceutical Co., Ltd.
Appearance
A colorless to pale yellow transparent injection solution in a plastic container for infusion.
Packaging
250 milliliters/box, 100 milliliters/box
Approval status
Expired

MFDS item code 201908091 · Notified 2019.11.26

This product's status changed to Expired on 2024.11.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Amino acid supplementation in severe hepatic impairment; treatment of hepatic coma
Who uses it
Adults
Adult dosage
○Adults: Administer by intravenous drip infusion a maximum daily dose of 1.5 g per kg of body weight as total amino acids (equivalent to 2100 mL daily for a body weight of 70 kg). ○Infusion rate: 1.7~2.1 mL per kg of body weight over 60 minutes (40~50 drops per minute for a body weight of 70 kg).

Ingredients

Manufacturer
Kujoo Pharmaceutical Co., Ltd.

Efficacy & effects

Amino acid supplementation in severe hepatic impairment; treatment of hepatic coma

  • Brain function damage
  • severe liver dysfunction
  • hepatic coma
View approved original text

The administration of non-oral amino acids in the treatment of severe liver dysfunction or liver failure, as well as hepatic coma, helps to prevent brain function damage and improve liver function. This treatment is particularly used in cases accompanied by or not accompanied by brain function damage due to liver disease. Patients should understand that the supplementation of non-oral amino acids plays an important role in supporting liver function and alleviating symptoms of hepatic coma in these situations. Therefore, this medication is used for the treatment of severe liver dysfunction and hepatic coma.

Dosage and Administration

Adult dosage

○Adults: Administer by intravenous drip infusion a maximum daily dose of 1.5 g per kg of body weight as total amino acids (equivalent to 2100 mL daily for a body weight of 70 kg). ○Infusion rate: 1.7~2.1 mL per kg of body weight over 60 minutes (40~50 drops per minute for a body weight of 70 kg).

Precautions

This medication must be used strictly according to the physician's instructions and should not be taken or administered arbitrarily. It should not be administered to patients with severely impaired kidney function or those with high blood urea nitrogen levels. Patients with amino acid metabolism disorders not associated with liver dysfunction should also avoid using this medication. It should not be administered to patients with impaired nitrogen utilization, cachexia, pulmonary edema, oliguria, or anuria. Patients with elevated serum sodium and chloride levels or those with alkalosis, as well as those with heart block or severe myasthenia gravis, should not use this medication. Caution should be exercised when administering it to patients who are overhydrated or have a history of myocardial infarction. It should be used with caution in patients with severe acidosis, congestive heart failure, severe heart failure, edema due to sodium retention, hyperkalemia, potassium retention, and impaired kidney function. While using this medication, rare allergic reactions such as skin rashes may occur, so it should be discontinued immediately if such symptoms appear. Gastrointestinal symptoms such as nausea or vomiting may also occasionally occur. Cardiac-related symptoms such as chest discomfort, palpitations, rapid pulse, and elevated blood pressure may also appear, requiring careful monitoring. Rapid infusion of large volumes may lead to metabolic acidosis. In addition, severe side effects such as chills, fever, headache, difficulty breathing, shock, bronchospasm, and urinary spasm may occur. If magnesium is included, symptoms of peripheral vasodilation may also occur. Metabolic complications such as metabolic acidosis, hypophosphatemia, alkalosis, hyperglycemia, diabetes, dehydration, rebound hypoglycemia, elevated liver enzymes, vitamin imbalances, electrolyte imbalances, and pediatric hyperammonemia may occur. Patients with decreased liver or kidney function may experience elevated blood urea nitrogen (BUN) levels. Severely impaired liver function patients may show serum amino acid imbalances or metabolic alkalosis, systemic nitrogen surplus, hyperammonemia, decreased consciousness, or coma. Periodic testing is necessary as serum ammonia levels may change depending on treatment effectiveness. When this medication is administered in large doses or used in conjunction with electrolyte-containing solutions, meticulous attention to electrolyte balance is essential. Overdosage may lead to metabolic alkalosis; therefore, solutions containing acetate ions should be used cautiously. In patients with histories of kidney, lung, or heart diseases, care should be taken to avoid excessive fluid administration. Diabetic patients should frequently monitor blood glucose levels while administering this medication. Patients with hyponatremia or liver and kidney dysfunction should have individualized dose adjustments and meticulous management of fluid and electrolyte status. This medication may reduce the effectiveness of certain antibiotics when used together; thus, it is essential to consult a physician or pharmacist regarding other medications used. Safety has not been established for pregnant women; therefore, it should only be administered when the benefits of treatment outweigh the risks. Pediatric patients may have immature liver function, so lower concentrations should ideally be used, and blood ammonia levels should be frequently monitored. Elderly patients may have decreased physiological functions; therefore, care should be taken to slow the administration rate and reduce the dosage. This medication contains electrolytes, and rapid infusion may cause chills or vomiting and lead to increased amino acid loss through the kidneys. When administering it, temperature should be adjusted to body temperature, and preparation and handling should be done in a sterile environment to reduce the risk of infection. Do not use if the solution is cloudy or discolored, and it should be used as quickly as possible after opening. Storage should be in a sealed container to prevent air or moisture ingress. The recommended storage temperature is between 1°C and 30°C at room temperature. This way, the drug's effectiveness can be maintained for a longer time.

Side effects

  • rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • elevated blood pressure
  • acidosis
  • chills
  • fever
Show 28 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary spasm
  • peripheral vasodilation
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes mellitus
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogen retention
  • hyperammonemia
  • loss of sensation
  • coma
  • changes in serum ammonia levels

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1°C and 30°C at room temperature to keep the medication effective for a longer time.

Appearance and packaging

Appearance

A colorless to pale yellow transparent injection solution in a plastic container for infusion.

Package unit

250 milliliters/box, 100 milliliters/box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.